Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia

Davide Rossi, Silvia Rasi, Valeria Spina, +21

Blood

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia

Davide Rossi, Silvia Rasi, Giulia Fabbri, +21

Blood

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia

Valter Gattei, Pietro Bulian, Maria Ilaria Del Principe, +10

Blood

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

Davide Rossi, Lodovico Terzi-di-Bergamo, Lorenzo De Paoli, +30

Blood

CD49d Is the Strongest Flow Cytometry–Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia

Pietro Bulian, Tait D. Shanafelt, Chris Fegan, +12

Journal of Clinical Oncology

CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival

Antonella Zucchetto, Dania Benedetti, Claudio Tripodo, +16

Cancer Research

Endothelial CellsVersus Cd38ImmunologyImmune RegulationPathology +14

Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult acute myeloid leukemia

Francesco Buccisano, Luca Maurillo, Alessandra Spagnoli, +19

Blood

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia

Davide Rossi, Valeria Spina, Riccardo Bomben, +22

Blood

Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study

Riccardo Bomben, Michele Dal Bo, Daniela Capello, +21

British Journal of Haematology

Italian Multicentre StudyMixed-phenotype Acute LeukemiaImmunologyPathologyClinical Features +15

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia

Erika Tissino, Dania Benedetti, Sarah E. M. Herman, +26

The Journal of Experimental Medicine